1,1'-Carbonyldiimidazole → 2-(3-(Trifluoromethyl)-4,5-dihydroindazole-1-yl)acetamido-4,5,6,7-tetrahydrothieno[2,3-c]pyran-3-carboxamide

HRID 1162746

Reaktionsgleichung

Reaktionsgleichung von HRID 1162746
[NH2:1][C:2]1[S:10][C:5]2[CH2:6][O:7][CH2:8][CH2:9][C:4]=2[C:3]=1[C:11]([NH2:13])=[O:12].[F:14][C:15]([F:30])([F:29])[C:16]1[C:24]2[CH2:23][CH2:22][CH2:21][CH2:20][C:19]=2[N:18]([CH2:25][C:26](O)=[O:27])[N:17]=1.C(N1C=CN=C1)(N1C=CN=C1)=O>C(Cl)Cl.CN(C=O)C>[F:30][C:15]([F:14])([F:29])[C:16]1[C:24]2[CH2:23][CH2:22][CH:21]=[CH:20][C:19]=2[N:18]([CH2:25][C:26]([NH:1][C:2]2[S:10][C:5]3[CH2:6][O:7][CH2:8][CH2:9][C:4]=3[C:3]=2[C:11]([NH2:13])=[O:12])=[O:27])[N:17]=1

Komponenten

5

Reaktionsbedingungen

Temperatur
120 °C

Versuchsvorschrift

2-amino-5,7-dihydro-4H-thieno[2,3-c]pyran-3-carboxamide (40 mg, 0.20 mmol) and 2-(3-(trifluoromethyl)-4,5,6,7-tetrahydroindazole-1-yl)acetic acid (50 mg, 0.20 mmol) were dissolved in DCM/DMF (3 mL/50 μL) and polymer supported carbonyldiimidazole (330 mg, 1.2 mmol/g, 0.396 mmol) added. The reaction mixture was heated at 120° C. for 10 min in the microwave. The reaction mixture was filtered washing with MeOH (10 mL), EtOAc (10 mL), and MeCN (10 mL). The filtrate was concentrated in vacuo to give a yellow gum. Purification by preparative reverse phase HPLC gave desired product as a white solid (7.6 mg, 0.018 mmol, 9%).

Aufarbeitung

  1. additionadded
  2. filtrationThe reaction mixture was filtered
  3. washwashing with MeOH (10 mL), EtOAc (10 mL), and MeCN (10 mL)
  4. concentrationThe filtrate was concentrated in vacuo
  5. customto give a yellow gum
  6. customPurification by preparative reverse phase HPLC

Quellen und Nachweise

ORD-Eintrag
ord-d35ec981d3be486f8f9b94200c0124db
Quelldatensatz
uspto-grants-2010_10
Patentnummer
US07820707B2

Verknüpfte Notizen

Wird geladen…